Trexquant Investment’s Entellus Medical, Inc. Common Stock ENTL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-9,303
Closed -$227K 1572
2017
Q4
$227K Buy
+9,303
New +$179K 0.02% 876

Trexquant Investment's ENTL Position: Q1 2018 in Review

Trexquant Investment sold out of Entellus Medical, Inc. Common Stock (ENTL) in Q1 2018, closing a stake of 9,303 shares — an estimated $227K sold.

Trexquant Investment first reported a position in ENTL in Q4 2017 and held it in 1 quarter. The position peaked at $227K in Q4 2017. 0 funds tracked by Wall St. Rank hold ENTL as of Q1 2018.

  • Trexquant Investment reported no remaining Entellus Medical, Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Trexquant Investment sold 9,303 Entellus Medical, Inc. Common Stock shares in Q1 2018, an estimated $227K.
  • Trexquant Investment first reported a position in Entellus Medical, Inc. Common Stock in Q4 2017 and held it in 1 quarter.
  • Trexquant Investment's Entellus Medical, Inc. Common Stock position peaked at $227K in Q4 2017.
  • 0 funds tracked by Wall St. Rank held Entellus Medical, Inc. Common Stock as of Q1 2018.

Based on Trexquant Investment's 13F filing for Q1 2018, filed 3 May 2018.